Investor Overview

Corporate Profile

HTG Molecular Diagnostics, Inc's. (“HTG”) mission is to empower precision medicine at the local level. In 2013, the company commercialized its HTG Edge instrument platform and a portfolio of multiplexed profiling panels that leverage HTG’s proprietary target protection chemistry. In 2014, the company launched the HTG EdgeSeq system that combines the power of HTG Edge chemistry and automation with NGS technology. The HTG EdgeSeq system enables fast and easy use of NGS instruments for molecular profiling.

Stock Quote

HTGM (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Up 0.02 (1.13%)
Data as of 12/15/17 4:00 p.m. ET

Recent News

HTG Molecular Diagnostics Reports 2017 Third Quarter Earnings
HTG Molecular Diagnostics to Announce Third Quarter 2017 Financial Results and Host Conference Call on Tuesday, November 7
HTG Molecular Diagnostics to Present at the Cantor Fitzgerald Global Healthcare Conference
HTG Announces Issuance of Two Method Patents Related to its Technology
More News >>

Upcoming Events

There are currently no events scheduled.
More Events >>
Data provided by Nasdaq. Minimum 15 minutes delayed.

Shareholder Tools

Print Page Print Page   E-mail Page E-mail Page   RSS Feeds RSS Feeds   E-mail Alerts E-mail Alerts